Nicholas Elias Houstis, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Exercise Tolerance | 7 | 2020 | 768 | 1.270 |
Why?
|
Stroke Volume | 8 | 2020 | 5006 | 0.750 |
Why?
|
Exercise Test | 8 | 2022 | 2073 | 0.670 |
Why?
|
Oxygen Consumption | 4 | 2021 | 1868 | 0.620 |
Why?
|
Heart Failure | 11 | 2021 | 10895 | 0.540 |
Why?
|
Ventricular Function, Left | 4 | 2020 | 3666 | 0.470 |
Why?
|
Exercise | 8 | 2022 | 5615 | 0.370 |
Why?
|
Boidae | 1 | 2022 | 15 | 0.220 |
Why?
|
Dyspnea | 2 | 2020 | 1303 | 0.210 |
Why?
|
Shock | 1 | 2023 | 318 | 0.190 |
Why?
|
Heart Rate | 3 | 2021 | 4092 | 0.190 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2023 | 476 | 0.180 |
Why?
|
Physical Conditioning, Animal | 1 | 2022 | 354 | 0.160 |
Why?
|
Reactive Oxygen Species | 1 | 2006 | 2076 | 0.160 |
Why?
|
Activin Receptors, Type II | 1 | 2019 | 127 | 0.160 |
Why?
|
Cardiovascular Physiological Phenomena | 2 | 2022 | 235 | 0.160 |
Why?
|
Pulmonary Wedge Pressure | 1 | 2019 | 264 | 0.160 |
Why?
|
Pulmonary Ventilation | 1 | 2020 | 374 | 0.160 |
Why?
|
Muscle, Skeletal | 4 | 2019 | 4925 | 0.140 |
Why?
|
Health Status | 2 | 2021 | 4034 | 0.140 |
Why?
|
Echocardiography, Doppler | 1 | 2020 | 935 | 0.140 |
Why?
|
Diastole | 1 | 2018 | 791 | 0.130 |
Why?
|
Myocardium | 2 | 2019 | 4772 | 0.130 |
Why?
|
Blood Proteins | 1 | 2020 | 1124 | 0.130 |
Why?
|
Metabolome | 1 | 2020 | 895 | 0.120 |
Why?
|
Hemodynamics | 2 | 2023 | 4196 | 0.120 |
Why?
|
Insulin Resistance | 2 | 2007 | 3864 | 0.110 |
Why?
|
Aging | 3 | 2020 | 8664 | 0.100 |
Why?
|
Metabolomics | 1 | 2020 | 1485 | 0.100 |
Why?
|
Cardiovascular Diseases | 3 | 2022 | 15160 | 0.100 |
Why?
|
Intensive Care Units | 1 | 2023 | 3680 | 0.090 |
Why?
|
RNA-Binding Proteins | 1 | 2019 | 1903 | 0.090 |
Why?
|
Hypertension, Pulmonary | 1 | 2020 | 1534 | 0.080 |
Why?
|
Motor Activity | 1 | 2019 | 2715 | 0.080 |
Why?
|
Physical Fitness | 2 | 2022 | 732 | 0.080 |
Why?
|
Systole | 2 | 2020 | 958 | 0.070 |
Why?
|
Proteomics | 1 | 2020 | 3638 | 0.070 |
Why?
|
Reference Values | 1 | 2014 | 4982 | 0.070 |
Why?
|
Metalloporphyrins | 1 | 2006 | 41 | 0.070 |
Why?
|
Acute-Phase Proteins | 1 | 2007 | 262 | 0.070 |
Why?
|
Body Mass Index | 2 | 2021 | 12721 | 0.070 |
Why?
|
3T3-L1 Cells | 1 | 2006 | 199 | 0.070 |
Why?
|
Catalase | 1 | 2006 | 221 | 0.070 |
Why?
|
Glucose Tolerance Test | 2 | 2006 | 1151 | 0.070 |
Why?
|
Male | 18 | 2023 | 350115 | 0.060 |
Why?
|
Mice, Obese | 1 | 2006 | 425 | 0.060 |
Why?
|
Predictive Value of Tests | 2 | 2020 | 15078 | 0.060 |
Why?
|
Macrophages | 2 | 2018 | 5660 | 0.060 |
Why?
|
Middle Aged | 12 | 2023 | 213390 | 0.060 |
Why?
|
Humans | 23 | 2023 | 744366 | 0.060 |
Why?
|
Heart | 1 | 2018 | 4464 | 0.060 |
Why?
|
Superoxide Dismutase | 1 | 2006 | 596 | 0.060 |
Why?
|
Comorbidity | 1 | 2017 | 10388 | 0.060 |
Why?
|
Oncogene Proteins | 1 | 2007 | 749 | 0.060 |
Why?
|
Thiazolidinediones | 1 | 2006 | 476 | 0.050 |
Why?
|
Transgenes | 1 | 2006 | 1009 | 0.050 |
Why?
|
Lung | 1 | 2020 | 9857 | 0.050 |
Why?
|
Oxygen | 2 | 2023 | 4189 | 0.050 |
Why?
|
Oxidative Phosphorylation | 1 | 2003 | 481 | 0.050 |
Why?
|
Female | 13 | 2023 | 380193 | 0.050 |
Why?
|
Rodentia | 1 | 2022 | 261 | 0.050 |
Why?
|
Aged | 8 | 2021 | 163288 | 0.050 |
Why?
|
Prognosis | 2 | 2020 | 29060 | 0.050 |
Why?
|
Oxidation-Reduction | 1 | 2006 | 2184 | 0.050 |
Why?
|
Follistatin-Related Proteins | 1 | 2019 | 48 | 0.040 |
Why?
|
Animals | 10 | 2022 | 168768 | 0.040 |
Why?
|
Signal Transduction | 2 | 2019 | 23404 | 0.040 |
Why?
|
Perfusion | 1 | 2023 | 1360 | 0.040 |
Why?
|
Obesity | 4 | 2023 | 12746 | 0.040 |
Why?
|
Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2019 | 126 | 0.040 |
Why?
|
Mice, Inbred C57BL | 4 | 2019 | 21833 | 0.040 |
Why?
|
Autocrine Communication | 1 | 2019 | 171 | 0.040 |
Why?
|
Antioxidants | 1 | 2006 | 1659 | 0.040 |
Why?
|
Activins | 1 | 2019 | 208 | 0.040 |
Why?
|
PPAR alpha | 1 | 2019 | 197 | 0.040 |
Why?
|
Insulin-Like Growth Factor II | 1 | 2019 | 272 | 0.040 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2019 | 430 | 0.040 |
Why?
|
Mice | 6 | 2020 | 81201 | 0.030 |
Why?
|
Blood Pressure | 2 | 2023 | 8551 | 0.030 |
Why?
|
Physical Exertion | 1 | 2019 | 695 | 0.030 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2019 | 555 | 0.030 |
Why?
|
Pressure | 1 | 2019 | 1203 | 0.030 |
Why?
|
Models, Animal | 1 | 2022 | 2173 | 0.030 |
Why?
|
Constriction, Pathologic | 1 | 2019 | 1107 | 0.030 |
Why?
|
Body Weight | 1 | 2006 | 4671 | 0.030 |
Why?
|
Risk Factors | 2 | 2022 | 72296 | 0.030 |
Why?
|
Adult | 7 | 2022 | 214052 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2023 | 1790 | 0.030 |
Why?
|
Pulmonary Gas Exchange | 1 | 2014 | 382 | 0.030 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2019 | 1335 | 0.030 |
Why?
|
Quantitative Trait Loci | 1 | 2020 | 2019 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2018 | 1200 | 0.030 |
Why?
|
Prospective Studies | 3 | 2021 | 53290 | 0.030 |
Why?
|
Ligands | 1 | 2019 | 3282 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2021 | 5077 | 0.020 |
Why?
|
Glucose | 2 | 2019 | 4398 | 0.020 |
Why?
|
Fatty Acids | 1 | 2019 | 1809 | 0.020 |
Why?
|
Genetic Loci | 1 | 2020 | 2575 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2019 | 2504 | 0.020 |
Why?
|
Myocytes, Cardiac | 1 | 2019 | 1629 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2017 | 77460 | 0.020 |
Why?
|
Cytokines | 1 | 2023 | 7323 | 0.020 |
Why?
|
Insulin | 2 | 2019 | 6582 | 0.020 |
Why?
|
Hematopoiesis | 1 | 2018 | 2073 | 0.020 |
Why?
|
Monocytes | 1 | 2018 | 2596 | 0.020 |
Why?
|
Risk | 1 | 2020 | 9688 | 0.020 |
Why?
|
Phosphorylation | 1 | 2019 | 8436 | 0.020 |
Why?
|
Echocardiography | 1 | 2020 | 5099 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8662 | 0.020 |
Why?
|
Cardiovascular System | 1 | 2015 | 831 | 0.020 |
Why?
|
Fibroblasts | 1 | 2018 | 4162 | 0.020 |
Why?
|
Homeostasis | 1 | 2018 | 3339 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2019 | 3817 | 0.020 |
Why?
|
Lipocalins | 1 | 2007 | 170 | 0.020 |
Why?
|
3T3 Cells | 1 | 2007 | 1101 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2021 | 13991 | 0.020 |
Why?
|
Young Adult | 2 | 2022 | 56429 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 2007 | 1828 | 0.020 |
Why?
|
Transcription Factors | 1 | 2003 | 12207 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2018 | 14561 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16367 | 0.010 |
Why?
|
Rats | 1 | 2019 | 24252 | 0.010 |
Why?
|
Myoblasts | 1 | 2003 | 238 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2020 | 63107 | 0.010 |
Why?
|
Stromal Cells | 1 | 2007 | 1355 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2020 | 12262 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15535 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2020 | 6486 | 0.010 |
Why?
|
Adipocytes | 1 | 2007 | 1185 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2019 | 18034 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2003 | 11726 | 0.010 |
Why?
|
Transfection | 1 | 2007 | 5895 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 40559 | 0.010 |
Why?
|
Time Factors | 1 | 2020 | 40075 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39052 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2007 | 6171 | 0.010 |
Why?
|
Hypertension | 1 | 2018 | 8479 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2007 | 6621 | 0.010 |
Why?
|
Lipids | 1 | 2007 | 3307 | 0.010 |
Why?
|
Down-Regulation | 1 | 2003 | 3001 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2007 | 3280 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2003 | 3921 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2019 | 57776 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2007 | 11486 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2007 | 12073 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2003 | 13035 | 0.000 |
Why?
|
Cells, Cultured | 1 | 2003 | 19233 | 0.000 |
Why?
|
Gene Expression Profiling | 1 | 2003 | 9445 | 0.000 |
Why?
|